Legal Representation
Attorney
James E. Bame
USPTO Deadlines
Next Deadline
1791 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-06-04)
Due Date
June 04, 2030
Grace Period Ends
December 04, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
23 events| Date | Code | Type | Description |
|---|---|---|---|
| Dec 7, 2024 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Nov 19, 2024 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Nov 19, 2024 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Sep 4, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Jun 4, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jun 4, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Mar 19, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Mar 19, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Feb 28, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Feb 28, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Feb 14, 2024 | RFNT | P | REFUSAL PROCESSED BY IB |
| Feb 12, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 7, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 7, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 7, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jan 25, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Jan 25, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Jan 10, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Jan 9, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jan 8, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| May 23, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| May 19, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| May 18, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Pharmaceuticals preparations for the treatment of ophthalmic diseases and conditions; Pharmaceuticals preparations for the treatment of ophthalmic diseases and conditions sold in prefilled syringes
Classification
International Classes
005